PALIVIZUMAB FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN CHILDREN WITH CYSTIC FIBROSIS: RESULTS OF A COCHRANE SYSTEMATIC REVIEW

被引：0
|
作者：
Saldanha, I. [1 ]
Mckoy, N. A. [1 ]
Robinson, K. A. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
PEDIATRIC PULMONOLOGY | 2010年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [41] Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis
    Lewis, Leonie
    Sinha, Ian
    Losty, Paul D.
    [J]. PEDIATRIC PULMONOLOGY, 2022, 57 (01) : 239 - 244
  • [42] Palivizumab prophylaxis in patients admitted to the pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV).
    Feller, AE
    Morrison, WE
    Straumanis, JP
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A92 - A92
  • [43] Use of palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis
    Speer, Michael E.
    Fernandes, Caraciolo J.
    Boron, Marnie
    Groothuis, Jessie R.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (06) : 559 - 561
  • [44] Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
    Wegzyn C.
    Toh L.K.
    Notario G.
    Biguenet S.
    Unnebrink K.
    Park C.
    Makari D.
    Norton M.
    [J]. Infectious Diseases and Therapy, 2014, 3 (2) : 133 - 158
  • [45] Respiratory syncytial virus (RSV) infection in children with medical complexity
    A. Lim
    M. L. Butt
    J. Dix
    L. Elliott
    B. Paes
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 171 - 176
  • [46] Clinical predictors of respiratory syncytial virus (RSV) infection in children
    Attia, MW
    Friedman, MJ
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 121A - 121A
  • [47] Respiratory syncytial virus (RSV) infection in children with medical complexity
    Lim, A.
    Butt, M. L.
    Dix, J.
    Elliott, L.
    Paes, B.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (01) : 171 - 176
  • [48] Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
    Mac, Stephen
    Sumner, Amanda
    Duchesne-Belanger, Samuel
    Stirling, Robert
    Tunis, Matthew
    Sander, Beate
    [J]. PEDIATRICS, 2019, 143 (05)
  • [49] Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease -: who should receive it?
    Sunnegårdh, J
    [J]. ACTA PAEDIATRICA, 2006, 95 (04) : 388 - 390
  • [50] Respiratory Morbidity in Prematurely Born Children Receiving Palivizumab Prophylaxis of Respiratory Syncytial Virus Disease
    Bjelica, Milena
    Dautovic, Gordana Vilotijevic
    Spasojevic, Slobodan
    Dermanovic, Marija
    Plazacic, Milica
    [J]. IRANIAN JOURNAL OF NEONATOLOGY, 2024, 15 (02)
12345